Grants & Scholarships

2018 NIDA Grant Awardee

AANP is pleased to announce that the recipient of this year’s NIDA Mentored Training Award in Substance Use Disorder Treatment Science is Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN, from Darmouth-Hitchcock Medical Center in Lebanon, New Hampshire. Dr. Broglio will work with Dr. Seddon Savage to develop an interprofessional education session on screening for substance use disorder in the oncology population. Congratulations and best of luck to both Dr. Broglio and Dr. Savage.

Amount of Funding

One award of $12,000 ($10,000 to applicant, $1,500 stipend to mentor) will be made for the year 2018. The funding cycle begins January 2018 and ends December 2018 (projects must be completed and reports submitted by December 31, 2018). Awards will be disbursed in three equal payments after the acceptance of proposal and then receipt and acceptance of the required progress reports.

Eligibility

• Current AANP Member who is certified and licensed, and is early in their SUD career (less than five years).
• Must have an established mentor with experience in substance use disorder treatment and/or research.
• Must not have a current or previous significant, individual project funding in the field of substance use disorder.

This award cannot support new, free-standing pilot studies, clinical trials, or clinical research studies. Any proposed activities such as secondary analyses or quality improvement initiatives must be eligible for IRB exemption.

Application Requirements

1. Cover sheet:
   a. Applicant's name
   b. Institution
2. Proposal consisting of:
   a. Abstract
   b. Candidate statement
   c. Training plan
   d. Project description
          i. Objectives
         ii. Background information
        iii. Proposed activities
   e. Timeline for funding cycle period
   f. Budget and justification
   g. Literature cited
   h. Other support
3. Letter detailing any current and previous funding
4. Letter of support from proposed Mentor
5. Letter of support from the applicant’s current department chair (or appropriate program director), if applicable
6. Applicant and Mentor’s current biosketches and CV

Formatting:

  Double-spaced

  One inch margins

  12-point font type

  Sequentially numbered pages

Application closed on Thursday, November 30, 2017 at 5:00 pm CST.

Program Activities and Requirements

• Brief bulleted quarterly reports from awardee and mentor: January 2018, March 2018, June 2018, and September 2018.
• 6-month narrative progress report June 30, 2018.
• Final narrative report at the end of funding cycle, December 31, 2018.

Attendance at the 2019 AANP National Conference, where Awardees will present a poster abstract of their work following the completion of award.

Attendance at the 2018 or 2019 NIDA Clinical Trials Network Annual Steering Committee Meeting, date and location to be announced.

All discoveries resulting from work supported in part by the NIDA Award should be made available to the public and scientific community through approved scientific channels such as national meetings and peer reviewed publications. Publications will acknowledge the support of NIDA and AANP. Two reprints of each publication should be forwarded to AANP and NIDA.

All applicants are responsible for ensuring their own adherence to all federal research regulations, certifications and assurances. Institutional agreement of acceptance of their role and responsibility for the oversight of the award and proposed activities will be requested through the application process.

Recipients will be contacted annually by the NIDA Blending Initiative following completion of the funding year regarding career paths, ongoing dissemination or implementation activities, leadership in promoting the adoption of evidence-based practices in clinical settings, subsequent grants/contracts obtained, and publications.

Examples of Appropriate Activities and Projects

Include, but not limited to:

• Identifying best practices or effective strategies or models for SUD education;
• Developing materials that could be used for quality improvement or integration of an evidence-based approach or process in a medical setting and conducting activities for quality improvement or adoption;
• Reviewing available curricula or training programs, identifying status of education on SUD diagnosis and treatment in various settings, and proposing and conducting activities to improve training;
• Identifying training gaps and research findings and/or products developed by NIDA or other federal agencies or professional associations that could bridge gaps, identifying potential partners for effective dissemination of these findings and disseminating them within existing or newly developed communication channels;
• Analysis of de-identified data from completed clinical trials such as those found on the NIDA Data Share website (https://datashare.nida.nih.gov/) to inform dissemination or implementation efforts;
• Analysis of de-identified data from electronic health records or registries such as the ACEP Clinical Emergency Data Registry (https://www.acep.org/cedr/) to characterize availability of data on substance use or practice patterns, identify gaps in the provision of evidence-based practices, and/or identify needs for dissemination or implementation.
• Coursework to strengthen formal training in substance use disorder research and;
• Other activities consistent with the goals of the Blending Initiative to accelerate the dissemination of research findings and implementation or adoption of evidence-based SUD treatment in clinical practice.